Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Drug-Related Side Effects and Adverse Reactions × Temozolomide × 90 days × Clear all

Sponsor

Conditions

Glioblastoma 48 Glioma 14 Brain Neoplasms 14 Neuroblastoma 10 Sarcoma, Ewing 8 Gliosarcoma 8 Astrocytoma 8 Medulloblastoma 7 Sarcoma 6 Rhabdomyosarcoma 6 Ependymoma 6 Recurrence 5 Osteosarcoma 5 Neoplasms 5 Melanoma 5 Diffuse Intrinsic Pontine Glioma 4 Small Cell Lung Carcinoma 3 Prostatic Neoplasms 3 Oligodendroglioma 3 Neoplasm Metastasis 3 Lymphoma 3 Colorectal Neoplasms 3 Wilms Tumor 2 Somatostatinoma 2 Rhabdoid Tumor 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroectodermal Tumors, Primitive 2 Lymphoma, Follicular 2

Interventions

Methylprednisolone 2 pegaspargase 1 Vincristine 1 Radiotherapy 1 Prednisone 1 Prednisolone 1 Methylprednisolone Hemisuccinate 1 Methotrexate 1 Mercaptopurine 1 Leucovorin 1 Infliximab 1 Hydrocortisone 1 Fecal Microbiota Transplantation 1 Etoposide 1 Drug Therapy 1 Doxorubicin 1 Dexrazoxane 1 Dexamethasone 1 Cytarabine 1 Cyclophosphamide 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡